Quarry LP’s Oric Pharmaceuticals ORIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$182K Sell
16,830
-5,010
-23% -$45.4K 0.02% 330
2026
Q1
$277K Buy
21,840
+5,840
+37% +$66.3K 0.05% 256
2025
Q4
$131K Buy
16,000
+15,275
+2,107% +$176K 0.02% 352
2025
Q3
$8.7K Sell
725
-167
-19% -$1.76K ﹤0.01% 1709
2025
Q2
$9.05K Buy
+892
New +$5.99K ﹤0.01% 1361

Other funds holding ORIC

Quarry LP's ORIC Position: Q2 2026 in Review

Quarry LP reduced its Oric Pharmaceuticals (ORIC) stake by 23% in Q2 2026, selling an estimated $45.4K and leaving 16,830 shares worth $182K. The position accounts for 0.02% of the portfolio, ranked #330.

Quarry LP first reported a position in ORIC in Q2 2025 and has held it in 5 quarters since. The position peaked at $277K in Q1 2026. 181 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Quarry LP held 16,830 shares of Oric Pharmaceuticals worth $182K as of Q2 2026.
  • Quarry LP sold 5,010 Oric Pharmaceuticals shares in Q2 2026, an estimated $45.4K.
  • Oric Pharmaceuticals made up 0.02% of Quarry LP's portfolio in Q2 2026, its #330 holding.
  • Quarry LP first reported a position in Oric Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Quarry LP's Oric Pharmaceuticals position peaked at $277K in Q1 2026.
  • 181 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.